6.
Abay S, Lucantoni L, Dahiya N, Dori G, Dembo E, Esposito F
. Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds. Malar J. 2015; 14:288.
PMC: 4513948.
DOI: 10.1186/s12936-015-0812-2.
View
7.
Begashaw B, Mishra B, Tsegaw A, Shewamene Z
. Methanol leaves extract Hibiscus micranthus Linn exhibited antibacterial and wound healing activities. BMC Complement Altern Med. 2017; 17(1):337.
PMC: 5485746.
DOI: 10.1186/s12906-017-1841-x.
View
8.
Dkhil M, Al-Quraishy S, Al-Shaebi E, Abdel-Gaber R, Thagfan F, Qasem M
. Medicinal plants as a fight against murine blood-stage malaria. Saudi J Biol Sci. 2021; 28(3):1723-1738.
PMC: 7938113.
DOI: 10.1016/j.sjbs.2020.12.014.
View
9.
Maslachah L, Widiyatno T, Yustinasari L, Plumeriastuti H
. Phenotypic approach artemisinin resistance in malaria rodent as model. Vet World. 2017; 10(7):790-797.
PMC: 5553149.
DOI: 10.14202/vetworld.2017.790-797.
View
10.
Shackelford C, Long G, Wolf J, Okerberg C, Herbert R
. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol. 2002; 30(1):93-6.
DOI: 10.1080/01926230252824761.
View
11.
Mishra A, Kaushik N, Sardar M, Sahal D
. Evaluation of antiplasmodial activity of green synthesized silver nanoparticles. Colloids Surf B Biointerfaces. 2013; 111:713-8.
DOI: 10.1016/j.colsurfb.2013.06.036.
View
12.
Myint M, Rasmussen C, Thi A, Bustos D, Ringwald P, Lin K
. Therapeutic efficacy and artemisinin resistance in northern Myanmar: evidence from in vivo and molecular marker studies. Malar J. 2017; 16(1):143.
PMC: 5383981.
DOI: 10.1186/s12936-017-1775-2.
View
13.
Webster A, Nagler E, Morton R, Masson P
. Chronic Kidney Disease. Lancet. 2016; 389(10075):1238-1252.
DOI: 10.1016/S0140-6736(16)32064-5.
View
14.
Mwaba C, Munsaka S, Bvulani B, Mwakazanga D, Chiluba B, Fitzwanga K
. Malaria is the leading cause of acute kidney injury among a Zambian paediatric renal service cohort retrospectively evaluated for aetiologies, predictors of the need for dialysis, and outcomes. PLoS One. 2023; 18(10):e0293037.
PMC: 10599569.
DOI: 10.1371/journal.pone.0293037.
View
15.
Hemaiswarya S, Kruthiventi A, Doble M
. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine. 2008; 15(8):639-52.
DOI: 10.1016/j.phymed.2008.06.008.
View
16.
Xu Y, Liu J, Han E, Wang Y, Gao J
. Efficacy of coenzyme Q10 in patients with chronic kidney disease: protocol for a systematic review. BMJ Open. 2019; 9(5):e029053.
PMC: 6530451.
DOI: 10.1136/bmjopen-2019-029053.
View
17.
Recordati C, De Maglie M, Bianchessi S, Argentiere S, Cella C, Mattiello S
. Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects. Part Fibre Toxicol. 2016; 13:12.
PMC: 4772516.
DOI: 10.1186/s12989-016-0124-x.
View
18.
Nosrati H, Hamzepoor M, Sohrabi M, Saidijam M, Assari M, Shabab N
. The potential renal toxicity of silver nanoparticles after repeated oral exposure and its underlying mechanisms. BMC Nephrol. 2021; 22(1):228.
PMC: 8212496.
DOI: 10.1186/s12882-021-02428-5.
View
19.
Barber B, William T, Grigg M, Parameswaran U, Piera K, Price R
. Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria. PLoS Pathog. 2015; 11(1):e1004558.
PMC: 4287532.
DOI: 10.1371/journal.ppat.1004558.
View
20.
Imenez Silva P, Mohebbi N
. Kidney metabolism and acid-base control: back to the basics. Pflugers Arch. 2022; 474(8):919-934.
PMC: 9338915.
DOI: 10.1007/s00424-022-02696-6.
View